Orna Staretz-Chacham1, M Aviram2, I Morag3, A Goldbart2, E Hershkovitz4. 1. Pediatric Metabolic Clinic, Pediatric Division, Soroka Medical Center, Ben-Gurion University, Beersheba, Israel. staretz@bgu.ac.il. 2. Pediatric Pulmonology Clinic, Pediatric Division, Soroka Medical Center, Ben-Gurion University, Beersheba, Israel. 3. Department of Pediatrics, The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel. 4. Pediatric Metabolic Clinic, Pediatric Division, Soroka Medical Center, Ben-Gurion University, Beersheba, Israel.
Abstract
Niemann-Pick disease type C (NPC) is a lysosomal storage disorder caused by mutations in either NPC-1 or NPC-2 genes, resulting in abnormal intracellular cholesterol trafficking. The estimated prevalence of NPC disease is 1: 120,000-150,000. Lung involvement has been described in only few patients with NPC, mostly NPC2. We describe a series of 12 patients, originating from six families all homozygotes to the p.R404Q (c.1211G > A) mutation of NPC1 gene; nine of them had significant pulmonary manifestations. All patients were followed in our medical center. Nine of the patients had pulmonary involvement, with recurrent pneumonia as the first manifestation in most, followed by recurrent wheezing episodes and subsequent development of interstitial lung disease with chronic need for oxygen support. Seven patients were reported of having interstitial disease by various imaging modalities. Conclusion: Pulmonary involvement in NPC1 is more common than previously reported. It is characterized as primary obstructive and restrictive lung disease and not only as part of neurologic sequel of NPC. It can lead to respiratory insufficiency and death from respiratory failure. What is Known: • Lung involvement has been described in only few patients with NPC. • Most reported NPC cases with pulmonary involvement were of NPC2. What is New: • Pulmonary involvement in NPC1 is more common than previously reported. • Pulmonary involvement in NPC1 should be considered as part of the disease and be thoroughly assessed and managed.
Niemann-Pick disease type C (NPC) is a lysosomal storage disorder caused by mutations in either NPC-1 or NPC-2 genes, resulting in abnormal intracellular cholesterol trafficking. The estimated prevalence of NPC disease is 1: 120,000-150,000. Lung involvement has been described in only few patients with NPC, mostly NPC2. We describe a series of 12 patients, originating from six families all homozygotes to the p.R404Q (c.1211G > A) mutation of NPC1 gene; nine of them had significant pulmonary manifestations. All patients were followed in our medical center. Nine of the patients had pulmonary involvement, with recurrent pneumonia as the first manifestation in most, followed by recurrent wheezing episodes and subsequent development of interstitial lung disease with chronic need for oxygen support. Seven patients were reported of having interstitial disease by various imaging modalities. Conclusion:Pulmonary involvement in NPC1 is more common than previously reported. It is characterized as primary obstructive and restrictive lung disease and not only as part of neurologic sequel of NPC. It can lead to respiratory insufficiency and death from respiratory failure. What is Known: • Lung involvement has been described in only few patients with NPC. • Most reported NPC cases with pulmonary involvement were of NPC2. What is New: • Pulmonary involvement in NPC1 is more common than previously reported. • Pulmonary involvement in NPC1 should be considered as part of the disease and be thoroughly assessed and managed.
Authors: S Palmeri; P Tarugi; F Sicurelli; R Buccoliero; A Malandrini; M M De Santi; G Marcianò; C Battisti; M T Dotti; S Calandra; A Federico Journal: Neurol Sci Date: 2005-07 Impact factor: 3.307
Authors: V Meiner; S Shpitzen; H Mandel; A Klar; Z Ben-Neriah; J Zlotogora; M Sagi; A Lossos; R Bargal; V Sury; R Carmi; E Leitersdorf; M Zeigler Journal: Genet Med Date: 2001 Sep-Oct Impact factor: 8.822
Authors: Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Ling Gao; Shaohui Huang; Yue Ning; Sheldon I Feinstein; Charles H Vite; Sandra R Bates Journal: PLoS One Date: 2013-07-02 Impact factor: 3.240
Authors: Adam M Lopez; Charina M Ramirez; Anna M Taylor; Ryan D Jones; Joyce J Repa; Stephen D Turley Journal: Dig Dis Sci Date: 2019-07-17 Impact factor: 3.199
Authors: Olga Bueno-Lozano; Sofía Valle-Guillén; Gerardo Rodríguez; Laura López de Frutos; Purificación Ventura-Faci Journal: An Pediatr (Engl Ed) Date: 2021-03-04
Authors: Jorge L Rodriguez-Gil; Laura L Baxter; Dawn E Watkins-Chow; Nicholas L Johnson; Cristin D Davidson; Steven R Carlson; Arturo A Incao; Kerri L Wallom; Nicole Y Farhat; Frances M Platt; Ryan K Dale; Forbes D Porter; William J Pavan Journal: Hum Mol Genet Date: 2021-11-30 Impact factor: 5.121